| Net Cash Provided by (Used in) Operating Activities |
$1,262,389 |
USD |
-291% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$298,207 |
USD |
-185% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$2,085,065 |
USD |
-3324% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
250,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
16,540,342 |
shares |
113% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$3,645,661 |
USD |
-10770% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$1,986,000 |
USD |
174% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$1,986,000 |
USD |
174% |
Q4 2024 |
FY 2024 |
| Depreciation |
$4,298 |
USD |
18% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$1,986,000 |
USD |
174% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
25,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$75,510,866 |
USD |
946% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$2,778 |
USD |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2025 |
Q3 2025 |